參考文獻(xiàn)/References:
[1] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診療指南(2022)[J].中國全科醫(yī)學(xué),2023,26(14):1671-1691.
[2] 中華中醫(yī)藥學(xué)會.絕經(jīng)后骨質(zhì)疏松癥(骨痿)中醫(yī)藥診療指南(2019年版)[J].中醫(yī)正骨,2020,32(2):1-13.
[3] 苗德勝,呂發(fā)明,楊新軍,等.王繼先教授以燥論治骨質(zhì)疏松癥[J].中醫(yī)正骨,2022,34(9):73-75.
[4] 童銘豪,余陽,秦路平,等.基于“一氣周流”理論辨治絕經(jīng)后骨質(zhì)疏松癥[J].中醫(yī)正骨,2022,34(4):58-60.
[5] 房謀昊,周航,陳天鵬,等.從“治痿獨(dú)取陽明”論治絕經(jīng)后骨質(zhì)疏松癥[J].中醫(yī)正骨,2021,33(8):49-50.
[6] 游翔宇,王想福,葉丙霖,等.補(bǔ)腎活血藥治療骨質(zhì)疏松癥的研究進(jìn)展[J].中醫(yī)正骨,2021,33(3):56-57.
[7] 汪運(yùn)富,遲華基.論“脾主為衛(wèi)”[J].山東中醫(yī)藥大學(xué)學(xué)報,2001,25(3):209-214.
[8] 華臻,彭竑程,尹玉寶,等.中醫(yī)藥從脾論治骨質(zhì)疏松癥[J].中國骨質(zhì)疏松雜志,2022,28(8):1223-1227.
[9] 張靜,王祿海.試論脾胃與免疫功能的相關(guān)性[J].陜西中醫(yī),2000,21(6):287.
[10] 劉杰民,黃貴華,紀(jì)云西,等.“脾為之衛(wèi)”的理論內(nèi)涵與免疫學(xué)外延探討[J].新中醫(yī),2011,43(5):3-5.
[11] 李宗芳,張澍.脾臟的基礎(chǔ)研究進(jìn)展與展望[J].西安交通大學(xué)學(xué)報(醫(yī)學(xué)版),2008,29(1):1-6.
[12] 姜婷,紀(jì)文巖,陸為民.從腸道菌群淺析“脾為之衛(wèi)”的科學(xué)內(nèi)涵與臨床應(yīng)用[J].中國中西醫(yī)結(jié)合雜志,2020,40(10):1268-1272.
[13] 周聯(lián),黃紹偉,羅霞,等.腸道黏膜免疫進(jìn)展為中藥免疫研究提供的機(jī)遇[J].中國免疫學(xué)雜志,2019,35(24):2945-2952.
[14] 吳秀,周聯(lián),羅霞,等.四君子湯多糖對脾虛小鼠腸道菌群及免疫功能的影響[J].中藥藥理與臨床,2014,30(2):12-14.
[15] 謝希,高曦,婁宏君,等.骨質(zhì)疏松癥的骨免疫機(jī)制及中藥單體干預(yù)研究[J].中醫(yī)學(xué)報,2023,38(12):2590-2597.
[16] SAXENA Y,ROUTH S,MUKHOPADHAYA A.Immunoporosis:role of innate immune cells in osteoporosis[J].Front Immunol,2021,12:687037.
[17] 毛未賢,張萌萌,馬倩倩,等.絕經(jīng)后骨質(zhì)疏松B細(xì)胞、T細(xì)胞亞群、免疫調(diào)控因子與骨密度相關(guān)性研究[J].中國骨質(zhì)疏松雜志,2020,26(12):1732-1736.
[18] YATSONSKY II D,PAN K,SHENDGE V B,et al.Linkage of microbiota and osteoporosis:a mini literature review[J].2019,10(3):123-127.
[19] 盛彤,謝培鳳,王新祥.原發(fā)性骨質(zhì)疏松癥從脾論治及相關(guān)機(jī)制探討[J].中華中醫(yī)藥雜志,2012,27(7):1922-1926.
[20] 梁煜,趙遠(yuǎn)紅.“肝與大腸相通”的理論內(nèi)涵初析[J].中西醫(yī)結(jié)合肝病雜志,2023,33(3):261-265.
[21] 鐘秋生,韓臨曉,陸向然,等.健脾益氣方對絕經(jīng)后女性骨質(zhì)疏松癥的臨床療效觀察[J].世界中西醫(yī)結(jié)合雜志,2015,10(3):378-380.
[22] 吳俊琪,林銘.甘草附子湯對骨質(zhì)疏松患者血清Semaphorin3A及骨代謝指標(biāo)影響[J].吉林中醫(yī)藥,2020,40(9):1199-1201.
[23] 胡栢均,吳宇峰.伍中慶教授歸脾湯治療骨質(zhì)疏松癥的經(jīng)驗[J].光明中醫(yī),2011,26(6):1102-1104.
[24] 易倩,張合富,李官翔,等.麥冬多糖對破骨細(xì)胞分化的影響研究[J].現(xiàn)代醫(yī)藥衛(wèi)生,2024,40(2):190-195.
[25] 李鴻儒,趙清輝,王永輝,等.丹皮酚對骨質(zhì)疏松骨折大鼠骨代謝的影響[J].中國矯形外科雜志,2023,31(24):2264-2269.
相似文獻(xiàn)/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補(bǔ)腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補(bǔ)腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[3]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):12.
[4]陳冠軍,陳揚(yáng),莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):19.
[7]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(08):20.
[8]史曉林,李春雯,張志強(qiáng).弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標(biāo)志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機(jī)制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(08):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(08):16.
[11]李嘉彤,李念虎.基于“脾腎-營衛(wèi)-絡(luò)脈”理論論治肌少-骨質(zhì)疏松癥[J].中醫(yī)正骨,2024,36(03):74.